-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Atara Biotherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q4 2024.
- Atara Biotherapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 7.49M shares, a 76.8% increase year-over-year.
- Atara Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 7.49M shares, a 76.8% increase from 2023.
- Atara Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.24M shares, a 95.8% decline from 2022.
- Atara Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 102M shares, a 8.88% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)